ESC Professional Premium Access

Heart failure pharmacotherapy - Sacubitril/valsartan

Event: ESC Congress 2022
Topic: Pharmacotherapy
Session type: Moderated ePosters
Date: 26 August 2022
Time: 15:15 - 16:00

Congress Session

8 presentations in this session

Haemodynamic forces as predictors of cardiac remodelling and outcome in heart failure with reduced ejection fraction treated with sacubitril/valsartan

Speaker: Assistant Professor A. Giannoni (Pisa, IT)
Thumbnail

Maximum dose sacubitril/valsartan in heart failure with reduced ejection fraction: does atrial fibrillation compromise the benefits?

Speaker: Doctor G. Oliveira Campos (Coimbra, PT)
Thumbnail

Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin aldosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials

Speaker: Professor A. Bielecka-Dabrowa (Lodz, PL)
Thumbnail

Effects of sacubitril valsartan on renal function in adults with heart failure: a systematic review and meta analysis of randomised controlled trials

Speaker: Professor A. Hernandez (Storrs, US)
Thumbnail

Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV)

Speaker: Assistant Professor K. Lee (Incheon, KR)
Thumbnail

Comparative effectiveness of sacubitril/valsartan versus angiotensin converting enzyme inhibitors/angiotensin receptor blockers in de novo heart failure patients

Speaker: Doctor H. Schwende (Basel, CH)
Thumbnail

The effectiveness of ARNI medication in patients, non-responder to cardiac resynchronization therapy

Speaker: Doctor K. Szabo (Debrecen, HU)
Thumbnail

Sacubitril/valsartan treatment: effect on left ventricular remodelling and fibrosis assessed by novel heart failure biomarkers

Speaker: Mrs A. Robles Mezcua (Malaga, ES)
Thumbnail

8 speakers from this session

Assistant Professor Alberto Giannoni

Sant'Anna School of Advanced Studies, Pisa (Italy)
1 presentation
0 follower

Doctor Gustavo Manuel Oliveira Campos

University Hospitals of Coimbra, Coimbra (Portugal)
0 follower

Professor Agata Magdalena Bielecka-Dabrowa

Medical University of Lodz, Lodz (Poland)
0 follower

Professor Adrian V Hernandez

University of Connecticut , Storrs (United States of America)
0 follower

Assistant Professor Kwan Yong Lee

Incheon Saint mary's hospital, Incheon (Korea (Republic of))
0 follower

Doctor Heike Schwende

Novartis Pharma AG, Basel (Switzerland)
0 follower

Doctor Krisztina Szabo

University of Debrecen, Debrecen (Hungary)
0 follower

Mrs Ainhoa Robles Mezcua

Virgin of Victory University Hospital, Malaga (Spain)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk